Asthma Allergy Immunology

4 Record Found

• Mepolizumab-Related Adverse Events in Severe Eosinophilic Asthma: A Real-Life Study

  Sakine NAZİK BAHÇECİOĞLU, Murat TÜRK, Emel ATAYIK, Gülden PAÇACI ÇETİN, Bahar ARSLAN, İnci GÜLMEZ, İnsu YILMAZ

  Abstract Full Text:PDF Recommended articles Mail to Author How to Cite

• Low Counts of Eosinophils After the 4th Dose of Mepolizumab May be an Independent Risk Factor for Sars-CoV-2 Transmission in Patients with Severe Asthma

  Emel ATAYIK, Gökhan AYTEKIN

  Abstract Full Text:PDF Recommended articles Mail to Author How to Cite

• The Frequency and Severity of COVID-19 in Patients Receiving Biological Agents and Risk Factors: Experience of an Allergy Clinic

  Sadan SOYYIGIT, Sengul BEYAZ, Zeynep CELEBI SOZENER

  Abstract Full Text:PDF Recommended articles Mail to Author How to Cite

• Allergic Bronchopulmonary Aspergillosis Treated with Mepolizumab and Omalizumab: Switching Biological Agents

  Zeynep YEGIN KATRAN, Ismet BULUT

  Abstract Full Text:PDF Recommended articles Mail to Author How to Cite